Multidetector computed tomography (MDCT) of the abdominal solid organs, including the liver and kidney, is an essential imaging modality of routine clinical practice for the diagnosis, treatment planning, and follow-up of many diseases. The diagnostic accuracy of CT examination is highly dependent on the imaging protocols and, in particular, on contrast media (CM) Purpose: Our objective was to compare the effects of different iodine concentrations on characterizing small renal lesions. Materials and Methods: Thirty-eight patients were enrolled in this study. All patients underwent an initial CT scan using 370 mgI/mL iodinated contrast media. Patients were then randomized into two groups for a follow-up CT. Group A (n = 19) received 250 mgI/mL iodinated contrast media, and group B (n = 19) received 300 mgI/mL contrast media. The mean Hounsfield units (HU values) of small renal lesions with a maximum size of less than 2 cm were calculated. Signal to noise ratios (SNR values) were likewise evaluated. Three uroradiologists assessed the lesion's conspicuity and the diagnostic influence of the artifact's proximity to the adjacent renal parenchyma. Results: In group A, there were significant differences between the HU values of renal lesions and those of the adjacent renal parenchyma between the initial and follow-up CT. Conversely, in group B, there was no significant difference. Moreover, SNR values showed no statistically significant difference between both groups. Regarding lesion conspicuity, only one reader identified a significant difference (p = 0.032) in group A; whereas in group B, there was no statistical difference. The artifact's proximity to the adjacent renal parenchyma did not appear to have any diagnostic influence on differentiating the two (p < 0.05).
With recent improvements in the temporal and spatial resolutions in MDCT, the need for a more efficient approach in the use of iodinated CM has increased (4) . Several studies investigated the influence of CM with different iodine concentration on parenchymal and vascular enhancement in body imaging (1, (5) (6) (7) .
Although the choice of contrast agent concentration and administration techniques are still controversial, many authors have shown that enhancement of the abdominal arteries directly correlates to the amount of iodine per second (8, 9) , which is also known as the "iodine flux" (10) . With greater iodine flux, the region of interest (ROI) will be higher in density. Conversely, because a lower amount of total iodine lowers the risk of contrastinduced nephropathy (11) (12) (13) , CT protocols should always find a compromise between the required contrast enhancement and the amount of iodine injected (10) .
Small renal masses (SRM) are usually defined by a diameter of up to 4 cm, and they constitute 48% to 66% of all newly diagnosed renal tumors and 38% of all excised renal masses (14) (15) (16) .
However, most incidental renal masses now detected on crosssectional imaging are less than 2.5 cm in size (17) . With increasing utilization of diagnostic imaging modalities, detection of smaller renal lesions has increased. Furthermore, the need for greater characterization of the detected small renal lesions, including contrast enhancement after the injection of CM, has increased. It has become critical for planning further treatment or evaluation. There have been several articles comparing the qualities of images derived from different iodine concentrations in the upper abdomen or renal arteries using 240, 300, or 370 mgI/ mL (18, 19) . However, no reports have characterized small renal lesions using these different iodine concentrations.
The purpose of this study is to compare the effects of two different iodine concentrations on the characterization of small renal lesions that are detected via MDCT and are less than 2 cm in diameter.
MATERIALS AND METHODS

Patient Population
This study was approved by the Institutional Review Board, and informed consents were obtained from each patient. Between September 2009 and February 2012, 38 patients who underwent both nephrectomy due to renal tumor and postoperative follow-up CT were enrolled in this study. Thirty-seven of 38 patients were confirmed to have renal cell carcinoma. One patient had oncocytoma. Patients consisted of 25 men and 13 women, with a mean age [± standard deviation (SD)] of 61 (± 9.5) years.
On both the initial and follow-up CT, the small renal lesions with a maximum diameter of less than 2 cm were evaluated.
These small lesions were thought to be mostly benign. Among Fig. 1 . Flow chart demonstrating the included patients. 38 patients underwent CT examination after injection of 370 mgI/mL contrast media. Subsequently, for the follow-up CT, the patients were randomized into two groups. Group A (n = 19) underwent their follow-up CT after injection of 250 mgI/mL contrast media, and group B (n = 19) underwent CT examination after injection of 300 mgI/mL contrast media. In addition, the influence of each artifact's proximity to the adjacent renal parenchyma in differentiating between both was also evaluated in both groups. The images were graded as 1 if the lesion was influenced by the artifact from CM in the collecting system. If not, the images were graded as 0.
Statistical Analysis
For quantitative assessment, a paired t-test was used to com- Table 1 shows the mean and SD of attenuation in small renal lesions and surrounding parenchyma in both groups. The mean HU of group A and group B was 44.9 (± 26.0) and 32.6 (± 28.6), respectively, when 370 mgI/mL of CM was injected. In group A, where 250 mgI/mL of CM was used on a follow-up CT, the mean HU was 32.3 (± 24.4). The mean HU was 31.8 (± 28.1) in the follow-up CT of group B, where 300 mgI/mL of CM was used. In group A, a comparison between 370 mgI/mL and 250 mgI/mL yielded significant differences in the HUs of small renal lesions (p = 0.002) and those of the adjacent renal parenchyma (p < 0.001) (Fig. 2) . In group B, with a comparison between 370 mgI/mL and 300 mgI/mL, there was no significant difference in the HUs of small renal lesions (p = 0.552) and those of the adjacent renal parenchyma (p = 0.279) (Fig. 3) .
RESULTS
Quantitative Evaluation
The quantitative assessment of image homogeneity, based on the comparison of SNR with different iodine concentrations, revealed that no significant statistical differences were found to be in evidence either in group A (370 mgI/mL vs. 250 mgI/mL, p = 0.144) or in group B (370 mgI/mL vs. 300 mgI/mL, p = 0.382). Table 2 shows the results of lesion conspicuity in both groups.
Qualitative Evaluation
In group A, where the concentrations of CM were 370 mgI/mL and 250 mgI/mL, readers 1 and 2 reported that there was no significant difference between images derived from 370 mgI/mL and 250 mgI/mL CM (p = 0.573 and 0.224), although reader 3 reported a significant difference (p = 0.032) between both. In group B, where the concentrations of CM were 370 mgI/mL and 300 mgI/mL, all three readers showed no statistical differences with respect to lesion conspicuity (p = 0.132, 0.086, and 0.380, respectively). Table 3 shows the influence of the artifact's proximity to the adjacent parenchyma. The Wilcoxon signed rank test revealed that there was no statistical difference in the number of cases that showed an influence of the proximity of the artifact on diagnostic differentiation from the adjacent renal parenchyma (p < 0.05).
The overall proportion of agreement among three reviewers was 94.7% in group A and ranged from 78.9% to 89.5% in group B.
DISCUSSION
The principal factors affecting the enhancement of CM in CT A B Fig. 3 . A small renal lesion of a 41-year-old male patient; imaged using 370 mgI/mL (A) and 300 mgI/mL of contrast medium (B). A. The HU of the small renal lesion, imaged with 370 mgI/mL of contrast medium, was 5.0. B. The HU of the same lesion, imaged with 300 mgI/mL of contrast medium, was 7.0. There was no significant difference in the HUs of the small renal lesions in group B. HU = Hounsfield unit (23) . To take full advantage of MDCT, contrast enhancement protocols and scan timing must be modified for each clinical imaging application. CT scanning parameters which critically affect the contrast enhancement include scan duration, scan direction, multiphasic acquisitions during different phases of contrast enhancement, and scan delay after CM injection.
CM injection protocols are determined by a combination of several factors, including CM volume (27) (28) (29) (30) (31) , CM concentration, rate of injection, and type of injection (27, 32) . The rationale of any injection protocol is to deliver an adequate amount of CM in order to obtain optimal parenchymal and vascular enhancement. In the liver, the parenchymal enhancement is directly dependent on the total amount of iodine injected. Thus, it is affected by the total volume of CM. It can be modulated on the basis of iodine concentration: The higher the iodine concentration, the lower the volume of injected CM (1, 5, 31) . For example, to achieve optimal parenchymal enhancement of the liver (around 50-60 HU), it is necessary to deliver around 500-750 mgI per kg of body weight (1). Conversely, vascular enhancement is directly dependent on the iodine delivery rate, which is the iodine load given per unit of time (1, 5) .
Intravenous CM are available commercially in a wide range of concentrations (from 240 to 370 mgI/mL). When the volume, injection rate, and duration of CM are fixed, a higher concentration CM will deliver a larger dose of iodine faster. This results in a higher magnitude of peak contrast enhancement and a wider temporal window for CT imaging at a given level of enhancement.
Recently, CM with a high iodine concentration (350 mgI/mL) have been commonly reported as being widely used with MDCT Thus, when evaluating small renal lesions, the use of 300 mgI/mL instead of 370 mgI/mL iodine CM would not change the results.
However, the use of 250 mgI/mL instead of 370 mgI/mL CM could reveal different results in the evaluation of small renal lesions. In qualitative evaluations regarding the conspicuity of small renal lesions, all three reviewers reported no significant difference in group B, where we compared the results of 370 mgI/mL and 300 mgI/mL CM. However, in group A, where we compared the results of 370 mgI/mL and 250 mgI/mL CM, one reviewer reported a significant difference between both. Our results suggest that a CM of 300 mgI/mL can replace 370 mgI/mLbut that a CM of 250 mgI/mL has limitations in replacing 370 mgI/mL (even though the diagnostic influence of the proximity of the artifact to the adjacent parenchyma was found to have been negligible).
The main limitation of our study is that small renal lesions we evaluated were not pathologically confirmed, although we assume that most renal lesions were benign cysts. However, regarding the most common clinical situation, our results proved to be helpful in evaluating incidentally-detected small renal lesions found in post-contrast CT study. The second limitation of our study is that the qualitative evaluation was subjective, despite the attempted quantitative evaluation by measuring the HUs of small renal lesions. However, it is also true that (as seen in other publications) subjective assessment by experienced radiologists is a common method for image quality analysis (23, 24) . The third limitation is that the number of cases in each group was small. Another limitation is that we used different CT machines, which might contribute to the confounding factors in this study.
These biases could not be controlled, and the comparison of enhancement is limited. Because the renal lesions are quite small, the measurement errors due to pseudoenhancement and/or the location of the renal lesions could affect the results.
In spite of these limitations, our results revealed that for the characterization of small renal lesions with less than 2 cm in diameter, 300 mgI/mL CM can be used instead of 370 mgI/mL.
However, our findings also showed that the use of 250 mgI/mL CM may reveal insufficient results as compared with the better CM of 370 mgI/mL. Lastly, because the quality of enhancement of renal mass has been shown to be variable based on how much iodine is used, more detailed renal mass evaluation follow-up studies are needed to more precisely identify the amount optimal for quality renal parenchymal enhancement.
